Diosmin: A Citrus-Derived Compound

Diosmin powder is a semisynthetic flavone glycoside (chemically identified as 3',5,7-trihydroxy-4'-methoxyflavone-7-rutinoside) derived from Hesperidin, which is extracted from immature Citrus Aurantium (bitter orange) fruit. Classified as both an Active Pharmaceutical Ingredient (API) and a nutraceutical raw material, diosmin powder functions as a venotonic and vascular-protective agent. It inhibits norepinephrine breakdown, prolonging venous tone and reducing venous capacitance. Widely used in pharmaceutical-grade formulations targeting Chronic Venous Insufficiency (CVI) and hemorrhoids, diosmin powder has become a reference ingredient in vascular health categories across European and North American markets.

Understanding Diosmin Powder: Properties, Benefits, and Uses

Chemical Profile and Physical Properties

Diosmin powder appears as a hygroscopic powder that ranges from grayish-yellow to light yellow. Diosmetin-7-O-Rutinoside is another name for it in the IUPAC list, and it comes from the citrus fruit Citrus Aurantium L. Purity grades are usually between 90% and 98%, and they come in EP, BP, USP, Micronized, and DC formats. Because the raw material absorbs both water and light, it needs to be stored in a way that keeps it dry, cool, and out of direct sunlight. This will keep it fresh for two to three years.

Mechanisms of Vascular Action

Diosmin powder works on the wall of the veins by protecting the small blood vessels and lowering the permeability of the capillaries. It stops the production of prostaglandins and the activation of white blood cells on the endothelium of the veins. This directly stops the breakdown of veins caused by inflammation. Lower-limb swelling and pain have been statistically significantly reduced in clinical studies, including tests using the 900 mg Micronized Purified Flavonoid Fraction (MPFF) product. Diosmin powder is the best API for CVI control methods across all European pharmacopeias because of its biochemical profile.

Validated Therapeutic Applications

Diosmin powder has been shown to be useful in a number of therapeutic areas. When B2B formulators are putting together product catalogs, these are the main uses that have been shown to work:

• Chronic Venous Insufficiency (CVI): Diosmin powder makes vein walls stronger and helps lymph flow better. Studies have shown that MPFF formulations can lower the size of the ankle by up to 10% after six months of treatment. This effect is well-documented in European phlebology standards.
• Hemorrhoid symptom management: A daily amount of 2000 mg of diosmin-based MPFF has been shown to significantly shorten the length of bleeding and ease the pain of acute hemorrhoidal episodes, according to randomized controlled study data reported in peer-reviewed surgical literature.
• Microcirculation and cosmeceutical use: When mixed with topical formulations, micronized diosmin powder helps get rid of dark circles under the eyes and tired legs by working on the capillary network below the skin's surface.

These apps make it easy for formulators to come up with unique SKUs for the personal care, nutrition, and medicine areas.

Diosmin Powder vs. Alternatives: Making Informed Product Choices

Diosmin vs. Hesperidin: Bioavailability and Therapeutic Differences

Hesperidin and diosmin powder both come from citrus fruits, but they have very different effects in the body. The metabolic precursor to diosmin is hesperidin, which has lower venous specificity on its own. Diosmin powder, on the other hand, has a stronger venotonic effect because its structure has been changed in a way that makes it more compatible with receptors in venous smooth muscle. The best combo in the business is still 90:10 Diosmin-Hesperidin. This is because the ratio makes vascular protection better than either substance could do on its own.

Powder vs. Capsule: Formulation Flexibility

Often, procurement teams compare compressed forms of diosmin to powder forms. Bulk diosmin powder gives you more options for dosage forms, like pills, sachets, oral solutions, and skin emulsions. Pre-encapsulated formats, on the other hand, cut down on the steps needed to handle the powder inside the capsule. For making a lot of medicines, you have to use diosmin powder that is micronized and has particles smaller than 5 microns. This makes sure that the content is the same when you're making tablets quickly at 500 mg and 1,000 mg dosage strengths.

Semisynthetic vs. Naturally Extracted Diosmin

Citrus peel doesn't have enough natural diosmin for direct extraction to be useful in business, so the semisynthetic route is the standard for pharmaceuticals. First, hesperidin is taken from Citrus Aurantium that is not fully grown yet. Next, diosmin is made through a controlled dehydrogenation process. This method gives constant purity profiles, heavy metal control, and pharmacopeial compliance—benefits that naturally extracted options can't always match. This semisynthetic method is mentioned in EP, BP, and USP monographs, which shows that it is accepted by regulators around the world.

Procurement Guide for Diosmin Powder: Finding Reliable Suppliers and Best Deals

Supplier Qualification Criteria

The process of choosing a good diosmin powder maker involves more than just comparing prices. Before sending out a buy order, procurement teams should ask for and look over the following set of paperwork:

• Pharmacopoeial compliance certificates: Make sure that the diosmin powder meets the requirements of EP, BP, and USP all at the same time. This is especially important for sellers who want to use the European drug application process, which requires that the Certificate of Suitability (CEP/COS) be in line with each other.
• COA and HPLC fingerprint data: There should be heavy metal profiles (lead, arsenic, cadmium, mercury), microbiological results, and HPLC chromatograms for each batch COA. The chromatograms should show the Diosmin-Hesperidin ratio (90:10 for MPFF).
• Regulatory certifications: FDA registration, ISO 22000, KOSHER, and HALAL certifications meet the needs of different markets from North America to the Middle East.

Checking these documents before placing a trial order lowers the risk of quality problems and makes it easier to send these documents to the government later on.

Bulk Ordering, Logistics, and Compliance

To get diosmin powder in bulk quickly at European ports like Rotterdam and Hamburg, you need to pay attention to the HS code classification for customs clearance. Buyers should make sure that the company selling diosmin powder has all the necessary trade paperwork, such as origin certificates and export compliance files. Strategic stockpile of raw materials held by the seller directly lowers lead time risk during high seasonal demand. This is especially true in the spring and summer, when sales of vascular health products tend to go up.

Sample Request and Audit Process

Before a full commercial order (500 kg–1 MT), there is usually an inquiry, an RFQ, a sample with a COA or TDS, a facility audit or video verification, a 25 kg trial order, and finally the full commercial order. At each step, paperwork is made that goes straight into the buyer's quality control system.

How to Use and Formulate Diosmin Powder for Optimal Results?

Dosage Guidelines for Adult Formulations

The usual dose for treating CVI is 900 mg to 1,000 mg of diosmin powder (as MPFF) every day, usually spread out over two doses. As a short-course treatment for hemorrhoids, a regimen of 2,000 mg per day for four days and then 1,000 mg for three days has been backed by evidence from clinical trials. When making over-the-counter (OTC) dietary supplements, the people who make them should make sure that the dosage suggestions they give are in line with the structure/function claim rules set out by the FDA DSHEA or appropriate European monographs.

Solubility, Mixing, and Compatibility

Diosmin powder doesn't dissolve well in water, which is the main problem with formulating it. Micronized diosmin powder solves this problem by making the particle size smaller, to less than 5 microns. This makes the surface area available for absorption in the digestive tract much larger. It is best to check for compatibility with vitamin C, horse chestnut extract (Aesculus hippocastanum), and butcher's broom (Ruscus aculeatus) when making with excipients, since these ingredients are scientifically paired with diosmin in categories that support circulation. Do not mix with very acidic materials without first testing for stability.

Packaging, Storage, and Transport

Because diosmin powder absorbs water, the first packaging should be made of materials that keep moisture out. For business-to-business shipments, double-lined 25 kg polyethylene drums are the standard. Transport in a cold chain is not necessary, but goods should not be exposed to humidity levels above 60% RH at any point in the logistics chain. Quality control on arrival is helped by the right paperwork, such as temperature and humidity logs for air freight.

Conclusion

Diosmin powder has been used for a long time in medicine and nutritional products that aim to improve artery health. Because it works like a venotonic, follows the rules set by EP, BP, and USP, and has a lot of clinical proof behind it, it is used as a standard ingredient in products for CVI, hemorrhoid, and microcirculation. When looking at sources, procurement teams should give more weight to suppliers that offer full documentation, micronized grades with verified particle size, and stable inventory to meet seasonal demand cycles. In competitive European and North American markets, picking the right diosmin powder maker lowers supply chain risk and speeds up regulatory timelines.

FAQ

1. What is the difference between regular and micronized diosmin powder?

Standard diosmin powder has particles that are 50–80 microns in size, which makes it harder for the body to absorb. When diosmin powder is micronized, the particles get smaller until they are less than 5 microns. This makes the powder about twice as bioavailable as non-micronized grades and is needed for MPFF-equivalent drugs.

2. Why is the 90:10 Diosmin-Hesperidin ratio clinically significant?

The approved mix of 90:10 diosmin to hesperidin has been used in clinical studies that have shown better vascular results. It's not just a mix of matter; the diosmin part is made by carefully removing hydrogen from hesperidin, which makes a chemically separate substance. HPLC fingerprint research proves that the formation is real and not a blend.

3. What certifications should I verify when sourcing diosmin powder?

For FDA registration, ISO 22000, KOSHER, HALAL, and pharmacopeial compliance documents (EP/BP/USP), please ask for them. For EU drug applications, make sure that a CEP or COS is available to help with later regulatory filings.

4. Is diosmin powder compatible with DSHEA structure/function claims?

Yes. Structure/function claims like "supports healthy circulation" or "promotes vascular comfort" are legal under FDA DSHEA as long as they are backed up by proof files. To back up these claims, your supplier should give you technical dossiers.

Partner with UNIWELL for Pharmaceutical-Grade Diosmin Powder Supply

UNIWELL has been making EP/BP/USP-compliant diosmin powder for more than ten years and has more than 100 metric tons of raw materials on hand. Orders usually get sent out in three business days. As a reliable provider of diosmin powder, we offer full COA/TDS paperwork, HPLC fingerprint data, and regulatory help for entering the EU and US markets. Get a sample right now to see for yourself the uniformity that your recipe team needs. Email us at info@uniwellbio.com.

References

1. Ramelet, A.A. Diosmin: A Review of Pharmacological Properties and Clinical Efficacy in Venous Disease. Angiology, 2000.

2. Lyseng-Williamson, K.A., & Perry, C.M. Micronised Purified Flavonoid Fraction: A Review of Its Use in Chronic Venous Insufficiency, Venous Ulcers and Haemorrhoids. Drugs, 2003.

3. European Pharmacopoeia Commission. Diosmin Monograph. European Pharmacopoeia, 10th Edition, 2020.

4. Jantet, G. Chronic Venous Insufficiency: Worldwide Results of the RELIEF Study. Angiology, 2002.

5. Katsenis, K. Micronized Purified Flavonoid Fraction (MPFF): A Review of Its Pharmacological Effects, Therapeutic Efficacy and Benefits in the Management of Chronic Venous Insufficiency. Current Vascular Pharmacology, 2005.

6. United States Pharmacopeia. Diosmin Monograph. USP–NF, 2022.